Randomized Controlled Trial
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Mar 27, 2025; 17(3): 100302
Published online Mar 27, 2025. doi: 10.4240/wjgs.v17.i3.100302
Table 2 Comparison of general characteristics of the patients, n (%)
Characteristic
QASN group (n = 68)
RN group (n = 72)
P value
Age (year), mean ± SD60.10 ± 9.6059.67 ± 8.890.947
BMI (kg/m²), mean ± SD24.75 ± 3.9425.50 ± 3.690.777
Gender--0.247
Male35 (51.9)29 (40.0)-
Female33 (48.1)43 (60.0)-
Disease type--0.518
Colon cancer35 (51.9)42 (57.8)-
Rectal cancer33 (48.1)30 (42.2)-
TNM staging--0.319
Phase I25 (36.5)18 (24.4)-
Phase II22 (32.7)27 (37.8)-
Phase III21 (30.8)27 (37.8)-
Educational level--0.507
College degree or above33 (48.5)29 (40.0)-
High school/vocational22 (32.3)24 (33.3)-
Junior high school or below13 (19.2)19 (26.7)-
Complications--0.471
Hypertension21 (30.8)29 (40.0)-
Type 2 diabetes25 (36.5)21 (28.9)-
Lacunar cerebral infarction16 (23.1)16 (22.2)-
Hypothyroidism6 (9.6)6 (8.9)-
Dukes stage--0.867
A17 (25.0)14 (20.0)-
B27 (40.4)29 (40.0)-
C16 (23.1)19 (26.7)-
D8 (11.5)10 (13.3)-